Early improvement in type 2 diabetes mellitus post Roux-en-Y gastric bypass in Asian patients

Singapore Medical Journal

Volumn 51, Issue 12, 2010, Pages 937-943

  Kiong, K L ^a   Ganesh, R ^b   Cheng, A K S ^b   Lekshiminarayanan, R ^b   Lim, S C ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Asian; Haemoglobin A1c; Morbid obesity; Roux en Y gastric bypass; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; ASIAN; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG UTILIZATION; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; REMISSION; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951847284     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 2000; 83 Suppl 1:S5-S8.
2. National Health Survey 1998. Epidemiology and Disease Control Department: Ministry of Health, Singapore, 1999.
3. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248-56.e5.
4. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010; 375:408-18.
5. Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report. National Institutes of Health, 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed March 28, 2010.
6. Ministry of Health, Singapore. Clinical Practice Guidelines for Diabetes 3/2006. Singapore: Ministry of Health, 2006:53.
7. Ganesh R, Leese T, Rao A D, Baladas HG. Laparoscopic adjustable gastric banding for severe obesity. Singapore Med J 2006; 47:661-9.
8. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240:236-42.
9. Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998; 227:637-44.
10. Oliván B, Teixeira J, Bose M, et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg 2009; 249:948-53.
11. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346:1623-30.
12. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201-4.
13. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30:1709-16.
14. Cases JA, Gabriely I, Ma XH, et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001; 50:348-52.
15. Hwa JJ, Fawzi AB, Graziano MP, et al. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 1997; 272(4 Pt 2):R1204-9.
16. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118:2992-3002.
17. Miyawaki K, Yamada Y, Yano H, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 1999; 96:14843-7.
18. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 2008; 31 Suppl 2:S290-6.
19. Pories WJ, Swanson M, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995; 222:339-52.
20. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-12.
21. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141:413-20.
22. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237:757-8.
23. MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1:213-20.
24. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS intervention study. Obes Res 1999; 7:477-85.
25. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238:467-85.
26. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22:1164-71.
27. Lee WJ, Chong K, Lee YC, et al. Effects of obesity surgery on type 2 diabetes mellitus Asian patients. World J Surg 2009:33:1895-903.
28. Dixon J, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabetic Med 2003; 20:127-34.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
30. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002; 347:1342-9.